182 related articles for article (PubMed ID: 37439840)
1. Combined early dynamic
Zhang Y; Dong Y; Yu W; Chen S; Yu H; Li B; Shi H
Abdom Radiol (NY); 2023 Oct; 48(10):3127-3134. PubMed ID: 37439840
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
[TBL] [Abstract][Full Text] [Related]
3. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
Schierz JH; Opfermann T; Steenbeck J; Lopatta E; Settmacher U; Stallmach A; Marlowe RJ; Freesmeyer M
J Nucl Med; 2013 Jun; 54(6):848-54. PubMed ID: 23528383
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923
[TBL] [Abstract][Full Text] [Related]
6. Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.
Wang SB; Wu HB; Wang QS; Zhou WL; Tian Y; Li HS; Ji YH; Lv L
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):324-30. PubMed ID: 25487755
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma.
Kobayashi T; Aikata H; Honda F; Nakano N; Nakamura Y; Hatooka M; Morio K; Morio R; Fukuhara T; Masaki K; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ohdan H; Awai K; Chayama K
J Comput Assist Tomogr; 2016; 40(4):524-30. PubMed ID: 26966955
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of perfusion and early-uptake
Wang S; Li B; Li P; Xie R; Wang Q; Shi H; He J
Jpn J Radiol; 2021 Nov; 39(11):1086-1096. PubMed ID: 34076855
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
12. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
[TBL] [Abstract][Full Text] [Related]
13. Investigating the value of pre-treatment
Lv J; Yin H; Mao W; Shi H
Abdom Radiol (NY); 2021 Jun; 46(6):2490-2497. PubMed ID: 33386905
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
Kim K; Kim SJ
Clin Imaging; 2021 Nov; 79():251-258. PubMed ID: 34157501
[TBL] [Abstract][Full Text] [Related]
16. Does dual-time-point
Wu B; Zhao Y; Zhang Y; Tan H; Shi H
Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
[TBL] [Abstract][Full Text] [Related]
17. Value of
Wu B; Zhang Y; Tan H; Shi H
Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
[TBL] [Abstract][Full Text] [Related]
18. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
Wu TH; Hatano E; Yamanaka K; Seo S; Taura K; Yasuchika K; Fujimoto Y; Nitta T; Mizumoto M; Mori A; Okajima H; Kaido T; Uemoto S
Surg Today; 2016 Nov; 46(11):1275-81. PubMed ID: 26983710
[TBL] [Abstract][Full Text] [Related]
19. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
20. The potential of
Jiang S; Gao X; Tian Y; Chen J; Wang Y; Jiang Y; He Y
Abdom Radiol (NY); 2024 May; 49(5):1444-1455. PubMed ID: 38265452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
